News and Announcements

GSK agrees to lower US drug prices across respiratory portfolio

By Iain Gilbert

Date: Monday 22 Dec 2025

(Sharecast News) - Drugmaker GSK has struck an agreement with the US to cut the cost of prescription medicines for American patients, including its broad respiratory portfolio used by more than 40m people with conditions such as asthma and COPD.
GSK said on Monday that the deal met all four actions...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page